Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma
Clinical trial NCT07688252 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07688252
- Sponsor
- Chang Gung Memorial Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2032-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.